Figure 2: NT5E 5’UTR variant genotype is associated with better OS, EFS, and reduced incidence of graft rejection
Kaplan-Meier survival curves showing associations between NT5E 5’UTR variant (rs2295890) genotype with Overall Survival (A), Event Free Survival (B), and graft rejection (C). Patients carrying the NT5E promoter variant genotype tended to have a better OS (p=0.25), EFS (p=0.12), and rejection-free survival (p=0.07) compared to those with wild-type genotype.